An-chih T. Wu

Taipei, TNQ 23564, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

KDM1A/HDAC2-driven epigenetic dysregulation maintains a drug-resistant, relapse-initiating glioblastoma cell niche at the peri-tumoral margin.

KDM1A/HDAC2-driven epigenetic dysregulation maintains a drug-resistant, relapse-initiating glioblastoma cell niche at the peri-tumoral margin.

Journal: Biochemical pharmacology

Published: February 23, 2026

Advances in Neoantigen-Based Cancer Vaccines.

Advances in Neoantigen-Based Cancer Vaccines.

Journal: Cancers

Published: December 04, 2025

A novel dual CDC25-HDAC inhibitor suppresses glioblastoma progression via chromosomal passenger complex disruption.

A novel dual CDC25-HDAC inhibitor suppresses glioblastoma progression via chromosomal passenger complex disruption.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 08, 2025

Correction: SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma.

Correction: SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 27, 2025

Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma Progression.

Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma Progression.

Journal: Cancer research

Published: January 02, 2024

Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects.

Rationally designed donepezil-based hydroxamates modulate Sig-1R and HDAC isoforms to exert anti-glioblastoma effects.

Journal: European journal of medicinal chemistry

Published: November 18, 2022

SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma.

SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 22, 2022

HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells.

HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 30, 2021

Alterations of serum biochemical parameters and tyrosine phosphorylation in kidney and liver of chronic stress-induced rats.

Alterations of serum biochemical parameters and tyrosine phosphorylation in kidney and liver of chronic stress-induced rats.

Journal: Brazilian journal of biology = Revista brasleira de biologia

Published: July 27, 2021

Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells.

Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells.

Journal: Cell death & disease

Published: June 17, 2021

ANGPTL4 Induces TMZ Resistance of Glioblastoma by Promoting Cancer Stemness Enrichment via the EGFR/AKT/4E-BP1 Cascade.

ANGPTL4 Induces TMZ Resistance of Glioblastoma by Promoting Cancer Stemness Enrichment via the EGFR/AKT/4E-BP1 Cascade.

Journal: International journal of molecular sciences

Published: October 04, 2019

Specificity protein 1-zinc finger protein 179 pathway is involved in the attenuation of oxidative stress following brain injury.

Specificity protein 1-zinc finger protein 179 pathway is involved in the attenuation of oxidative stress following brain injury.

Journal: Redox biology

Published: October 03, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026